Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria.

Leuret, Oriane

Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria. [electronic resource] - Journal of inherited metabolic disease Nov 2012 - 975-81 p. digital

Publication Type: Journal Article; Multicenter Study

1573-2665

10.1007/s10545-012-9464-3 doi


Age Factors
Biopterins--administration & dosage
Child, Preschool
Female
France
Genotype
Humans
Infant
Infant, Newborn
Male
Mutation
Phenylalanine--administration & dosage
Phenylalanine Hydroxylase--genetics
Phenylketonurias--blood
Retrospective Studies
Treatment Outcome